{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:07:43Z","timestamp":1792886863742,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jfma.2023.05.021","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T11:35:03Z","timestamp":1686137703000},"page":"S91-S97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S2","title":["How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?"],"prefix":"10.1016","volume":"123","author":[{"given":"Jin-Ying","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9148-8667","authenticated-orcid":false,"given":"Yi-Yao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-2868","authenticated-orcid":false,"given":"Ting-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hsien","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0884-9098","authenticated-orcid":false,"given":"Yen-Ta","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Shuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2609-0716","authenticated-orcid":false,"given":"Leay Kiaw","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-0991","authenticated-orcid":false,"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3885-6600","authenticated-orcid":false,"given":"Hao-Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5278-3540","authenticated-orcid":false,"given":"Hsien-Li","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6602-5532","authenticated-orcid":false,"given":"Charles","family":"Jia-Yin Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan-Dun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Tah","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Hsuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jfma.2023.05.021_bib1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","article-title":"Case detection and diagnosis of primary aldosteronism - the consensus of Taiwan Society of Aldosteronism","volume":"116","author":"Wu","year":"2017","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.jfma.2023.05.021_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jch.14117","article-title":"Confounders of the aldosterone-to-renin ratio when used as a screening test in hypertensive patients: a critical analysis of the literature","volume":"23","author":"Veldhuizen","year":"2021","journal-title":"J Clin Hypertens"},{"issue":"2","key":"10.1016\/j.jfma.2023.05.021_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/jch.14173","article-title":"The effect of medication on the aldosterone-to-renin ratio. A critical review of the literature","volume":"23","author":"Alnazer","year":"2021","journal-title":"J Clin Hypertens"},{"issue":"3","key":"10.1016\/j.jfma.2023.05.021_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.31128\/AJGP-07-19-4995","article-title":"Screening for primary aldosteronism: how to adjust existing antihypertensive medications to avoid diagnostic errors","volume":"49","author":"Gurgenci","year":"2020","journal-title":"Aust J Gen Pract"},{"key":"10.1016\/j.jfma.2023.05.021_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.684111","article-title":"The effect of antihypertensive medications on testing for primary aldosteronism","volume":"12","author":"Jedrusik","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jfma.2023.05.021_bib6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jfma.2023.05.021_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0002-9149(91)90438-Q","article-title":"Effects of doxazosin on blood pressure, renin-angiotensin-aldosterone and urinary kallikrein","volume":"67","author":"Oliveros-Palacios","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jfma.2023.05.021_bib8","series-title":"The effects of verapamil, hydralazine, and doxazosin on renin, aldosterone, and the ratio thereof","author":"Veldhuizen","year":"2021"},{"issue":"6","key":"10.1016\/j.jfma.2023.05.021_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jfma.2023.05.021_bib10","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2016-3821","article-title":"Effect of moxonidine on the aldosterone\/renin ratio in healthy male volunteers","volume":"102","author":"Ahmed","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jfma.2023.05.021_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.HYP.8.10.859","article-title":"Antihypertensive and metabolic effects of diltiazem and nifedipine","volume":"8","author":"Schulte","year":"1986","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.jfma.2023.05.021_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/jcem-57-2-339","article-title":"Effects of intravenous and oral verapamil upon pressor and adrenal steroidogenic responses in normal man","volume":"57","author":"Guthrie","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jfma.2023.05.021_bib13","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1210\/jc.2010-0225","article-title":"Effect of atenolol on aldosterone\/renin ratio calculated by both plasma Renin activity and direct Renin concentration in healthy male volunteers","volume":"95","author":"Ahmed","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jfma.2023.05.021_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cen.12882","article-title":"beta-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension","volume":"84","author":"Browne","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"11","key":"10.1016\/j.jfma.2023.05.021_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jash.2015.08.003","article-title":"Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension","volume":"9","author":"Giles","year":"2015","journal-title":"J Am Soc Hypertens"},{"issue":"2","key":"10.1016\/j.jfma.2023.05.021_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/HJH.0000000000000775","article-title":"A cross-sectional study of the effects of beta-blocker therapy on the interpretation of the aldosterone\/renin ratio: can dosing regimen predict effect?","volume":"34","author":"Griffin","year":"2016","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.jfma.2023.05.021_bib17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3803\/EnM.2020.797","article-title":"Changes in glucose metabolism after adrenalectomy or treatment with a mineralocorticoid receptor antagonist for primary aldosteronism","volume":"35","author":"Lin","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"6","key":"10.1016\/j.jfma.2023.05.021_bib18","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa080","article-title":"Effects of mineralocorticoid and AT1 receptor antagonism on the aldosterone-renin ratio in primary aldosteronism-the EMIRA study","volume":"105","author":"Rossi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jfma.2023.05.021_bib19","doi-asserted-by":"crossref","first-page":"e3655","DOI":"10.1210\/clinem\/dgab290","article-title":"Mineralocorticoid receptor antagonist effect on aldosterone to renin ratio in patients with primary aldosteronism","volume":"106","author":"Pecori","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jfma.2023.05.021_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.jfma.2023.05.021_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-57-5-892","article-title":"Single dose captopril as a diagnostic test for primary aldosteronism","volume":"57","author":"Lyons","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jfma.2023.05.021_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjhyper.2004.08.025","article-title":"Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives","volume":"18","author":"Lamarre-Cliche","year":"2005","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.jfma.2023.05.021_bib23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/HYPERTENSIONAHA.120.14871","article-title":"Effects of ramipril on the aldosterone\/renin ratio and the aldosterone\/angiotensin II ratio in patients with primary aldosteronism","volume":"76","author":"Guo","year":"2020","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.jfma.2023.05.021_bib24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2169\/internalmedicine.49.2749","article-title":"Plasma renin activity and aldosterone concentration are not altered by the novel calcium channel antagonist, azelnidipine, in hypertensive patients","volume":"49","author":"Kondo","year":"2010","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.jfma.2023.05.021_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/1470320312463833","article-title":"Screening for primary aldosteronism in a primary care unit","volume":"14","author":"Volpe","year":"2013","journal-title":"J Renin-Angiotensin-Aldosterone Syst JRAAS"},{"issue":"11","key":"10.1016\/j.jfma.2023.05.021_bib26","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.jfma.2023.05.021_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2125.1984.tb02458.x","article-title":"Effect of indapamide on the renin-aldosterone system, and urinary excretion of potassium and calcium in essential hypertension","volume":"18","author":"Danielsen","year":"1984","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623001900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623001900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:51:55Z","timestamp":1760539915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623001900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":27,"alternative-id":["S0929664623001900"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.05.021","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}